Patents Assigned to NANO TARGETING & THERAPY BIOPHARMA INC. - Justia Patents Search

Patents Assigned to NANO TARGETING & THERAPY BIOPHARMA INC.

Surface-modified mesoporous silica nanoparticle for blood-brain barrier penetration,tumor targeting and cancer metastasis treatment, methods of production and uses thereof

Patent number: 11419826

Abstract: The present disclosure relates to mesoporous silica nanoparticles (MSNs) with specific modifications as drug delivery systems containing both tumor targeting and blood-brain barrier (BBB) penetration properties suitable for cancer treatment and/or CNS disease treatment. The present disclosure also relates to method of preparing MSNs and the MSNs prepared by the method as described herein.

Type: Grant

Filed: April 30, 2020

Date of Patent: August 23, 2022

Assignee: NANO TARGETING & THERAPY BIOPHARMA INC.

Inventors: Cheng-Hsun Wu, Yi-Ping Chen, Si-Han Wu, Chung-Yuan Mou